FOLH1 and prostate cancer: Several recent studies have revealed accurate primary staging and restaging after biochemical recurrence of prostate cancer (PC) using Gallium-68 Prostate Specific Membrane Antigen (68Ga -PSMA PET/CT) [1–3].